As Bayer’s acquisition of Monsanto draws to a close, several assets related to the seed and chemical operations of the new combined company have been identified by regulators as causing anti-trust issues in certain markets. As a result, these assets are required to be divested in order for the transaction to finalise. This includes Bayer’s glufosinate and LibertyLink (glufosinate tolerance) operations, as well as several key row crop seed businesses. BASF has entered a provisional agreement with Bayer to acquire these assets. This AgBioInvestor Market Insight will discuss Bayer’s seed business in 2016, the revenue of the seed operations scheduled for divestment and BASF’s seed business global ranking once the deal has been completed.
Your subscription level does not currently cover this area of our services. Please contact us to find out how to gain access.